secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2024-10-16T23:59:59+00:00
Accession:  0001193125-24-237838
Event type: other
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics to raise ~$10M via stock/warrant offering; cancels prior warrants
--------------------------------------------------------------------------------

- Issuing 3M shares + pre-funded warrants for 333K shares + Series C warrants for 3.33M shares at $3.00 combined price.
- Gross proceeds ~$10M; closing expected Oct 16, 2024.
- Cancelling Series A warrants for 3.25M shares issued July 2024.
- Placement agent Maxim Group LLC receives 5.25% fee.
- Directors and officers enter 30-day lock-up.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000119312524237838/0001193125-24-237838-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000119312524237838/d816394d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-237838

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer